CRISIL EBITDA per Share
The EBITDA per Share of CRISIL (CRISIL.NS) as of Aug 13, 2026 is 150.70 INR. In the previous year, EBITDA per Share was 124.58 INR — a change of 20.96% (higher).
Get this data via API
Financial Data API
EBITDA per Share
150.70INR
YoY
20.96%
Last updated:
EBITDA per Share of CRISIL is 2026 150.70 INR. EBITDA per Share of CRISIL was 2025 124.58 INR. It decreases by 20.96% higher compared to the previous year.
Access this data via the Eulerpool API
CRISIL Stock analysis
What does CRISIL do? CRISIL Ltd is an Indian company specializing in financial and economic analysis. It was founded in 1987 and is headquartered in Mumbai. CRISIL provides credit risk assessment, ratings, market research, consulting, and training services primarily in the Indian market but also operates internationally. Its ratings division is the most well-known and the company is a leading player in the Indian rating market. CRISIL also offers ratings for structured finance products and provides consulting services in areas such as market research, strategy development, risk management, corporate finance, and valuation. In addition, CRISIL has an education division that offers courses and certifications in finance-related topics. The company is part of the global rating agency Standard & Poor's (S&P), which acquired a majority stake in CRISIL in 2016. CRISIL is one of the most popular companies on Eulerpool.
Frequently Asked Questions about CRISIL stock
EBITDA per Share of CRISIL is 150.70 INR in 2026.
EBITDA per Share of CRISIL changed from 124.58 INR to 150.70 INR, representing a 20.96% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBITDA per Share CRISIL since 2006 – with annual values, charts, and detailed analysis.
EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.
Access this data via the Eulerpool API
Income Statement — CRISIL
All Key Metrics — CRISIL
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth